Information Library

Late Phase Studies

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • The New Health Clinical Brochure

    August 31, 2010
    Japanese version available for download.

  • ISPOR 13th Annual European Congress

    November 6 - November 9, 2010
    Quintiles will be exhbiting, sponsoring and presenting at ISPOR's 13th Annual European Congress, November 6-9, 2010 in Prague.

  • Executive Vision Forum 2010: Convergence of Stakeholders

    July 9, 2010
    A Holistic Approach to Patient Outcomes - Brian Sweet, CPO, WellPoint. Presentation about the convergence of stakeholders.

  • Post-Market Advantage

    June 18, 2010
    Get 360-degree insight with an ally who knows you.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Data-Driven Market Success

    May 14, 2010
    Steering the largest post-marketing diabetes study ever conducted, Quintiles was able to stay flexible and successfully scale up to an eight-country study with more than 55,000 patients, even with the operational challenges of multiple affiliates and staggered database locks.

  • Clinical – smarter trials, accelerated outcomes

    April 2, 2010
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • The Right Balance

    March 31, 2010
    Through creative strategies and proactive measures, learn how Quintiles achieved both the recruitment targets and database lock eight months early.

  • PharmAsia News Article Reprint

    March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

  • The Value of Reviewing Existing EU Risk Management Plans

    February 12, 2010
    Drug Safety experts Cheryl Key, Barry Mulchrone and Karen Wai describe an electronic database for tracking RMPs for drugs approved in the European Union and explain why it is crucial for sponsors submitting marketing applications to have a thorough knowledge of safety plans already required for similar products.

Page 1 of 2 (11 results)

Subscribe to Email Based on Your Interests

Set preferences